Tuberculosis (TB), transmitted by the bacteria Mycobacterium tuberculosis has been a global epidemic for years. The evidence for infection with TB is centuries old. It can have an indolent course, and may remain inactive for years in individuals with the possibility of reactivation at any time, causing widespread systemic symptoms. The treatment and management of TB has become more effective over the years. It is estimated that more than one-third of the world population, especially in poor and developing countries are harboring this bacterium with varying manifestations of the disease from no symptoms to life-threatening infections. This manuscript describes the history of the disease and the discoveries. It also includes the recent advances and challenges facing the world and how governments and organizations are working together to control this disease.
KeywordsTuberculosisMulti-Drug ResistanceTuberculosis in India
Sulis, G., Roggi, A., Matteelli, A. and Raviglione, M. (2014) Tuberculosis: Epidemiology and Control. Mediterranean Journal of Hematology and Infectious Diseases, 6, e2014070. https://doi.org/10.4084/mjhid.2014.070
World Health Organization (2018) Tuberculosis Key Facts 2018. https://www.who.int/en/news-room/fact-sheets/detail/tuberculosis
Zink, A., Sola, C., Reischl, U., Grabner, W., Rastogi, N., Wolf, H. and Nerlich, G. (2003) Characterization of Mycobacterium tuberculosis Complex DNAs from Egyptian Mummies by Spoligotyping. Journal of Clinical Microbiology, 41, 359-367. https://doi.org/10.1128/JCM.41.1.359-367.2003
Daniel, T.M. and Iverson, P.A. (2015) Hippocrates and Tuberculosis. The International Journal of Tuberculosis and Lung Disease, 19, 373-374. https://doi.org/10.5588/ijtld.14.0736
Herzog, H. (1998) History of Tuberculosis. Respiration, 65, 5-15. https://doi.org/10.1159/000029220
Moulis, G. (2012) Scrofula, the King’s Evil. Canadian Medical Association Journal, 184, 1061. https://doi.org/10.1503/cmaj.111519
Sternbach, G. (1996) Percivall Pott: Tuberculosis Spondylitis. Journal of Emergency Medicine, 14, 79-83. https://doi.org/10.1016/0736-4679(95)02053-5
Doetsch, R. (1978) Benjamin Marten and His “New Theory of Consumptions.” Micriobiolical Reviews, 42, 521-528.
Keers, R.Y. (1978) Pulmonary Tuberculosis: A Journey Down the Centuries. Bailliere-Tindall, London.
Ferlinz, R. (1995) Die Tuberkulose in Deutschland und das deutsche Zentralkomitee zur Bekampfung der Tuberkulose. Pneumologie, 49, 617-632.
Loffler, W. (1958) Geschichte der Tuberkulose. In: Hein, J., Kleinschmidt, H. and Uehlinger, E., Eds., Handbuch der Tuberkulose, Stuttgart, Thieme.
Ayvazian, L.F. (1993) History of Tuberculosis. In: Reichman, L.B. and Hershfield, Eds., Tuberculosis, Dekker, New York.
Koch, R. (1901) The Fight against Tuberculosis in Light of the Experience Gained in the Successful Combat of Other Infectious Diseases. Boston Medical and Surgical Journal, 145, 109-115. https://doi.org/10.1056/NEJM190108011450501
Sakula, A. (1979) Robert Koch (1843-1910): Founder of the Science of Bacteriology and Discoverer of the Tubercle Bacillus. British Journal of Diseases of the Chest, 73, 389-394. https://doi.org/10.1016/0007-0971(79)90078-0
Hardy Diagnostics. Lowenstein Jensen (LJ) Agar Instructions for Use. https://catalog.hardydiagnostics.com/cp_prod/Content/hugo/LJMedia.htm
UK Government. Housing of the Working Classes Act 1885. http://www.legislation.gov.uk/ukpga/Vict/48-49/72/enacted
Ferlinz, R. (1995) Die Tuberkulose in Deutschland und das deutsche Zentralkomitee zur Bekampfung der Tuberkulose. Pneumologie, 49, 617-632.
Pratt, J.H. (1944) The Evolution of Rest Treatment of Pulmonary Tuberculosis. The American Review of Tuberculosis, 50, 185-201.
Sigerist, H.E. (1961) A History of Medicine. Oxford University Press, London.
Bochalli, R. (1959) Die Entwicklung der Tuberkuloseforschung in der Zeit von 1878 bis 1959. Stuttgart, Thieme.
Luchino, F. (1982) BCG Vaccination. The American Review of Respiratory Disease, 125, 70-72.
Bryder, L. (2014) The Medical Research Council and Treatments for Tuberculosis before Streptomycin. Journal of the Royal Society of Medicine, 107, 409-415. https://doi.org/10.1177/0141076814548663
Sakula, A. (1983) Carlo Forlanini, Inventor of Artificial Pneumothorax for Treatment. Thorax, 38, 326-332. https://doi.org/10.1136/thx.38.5.326
Sakula, A. (1988) Selman Waksman (1888-1973), Discoverer of Streptomycin: A Centenary Review. British Journal of Diseases of the Chest, 82, 23-31. https://doi.org/10.1016/0007-0971(88)90005-8
Davies, P.D. (2000) Tuberculosis: The Global Epidemic. Journal of the Indian Medical Association, 98, 100-102.
Sandhu, G. (2011) Tuberculosis: Current Situation, Challenges, and Overview of Its Control Programs in India. Journal of Global Infectious Diseases, 3, 143-150. https://doi.org/10.4103/0974-777X.81691
Gupta, I. and Guin, P. (2010) Communicable Disease in the South-East Asia Region of the World Health Organization: Towards a More Effective Response. Bulletin of the World Health Organization, 88, 199-205. https://doi.org/10.2471/BLT.09.065540
Sandiford, P. (1999) WHOs DOTS Strategy. Directly Observed Therapy. The Lancet, 353, 755. https://doi.org/10.1016/S0140-6736(05)76125-0
UNICEF India (2016) What We Do. http://unicef.in/WhatWeDo
Americares (2016) What We Do. http://www.americares.org/what-we-do
Centers for Disease Control and Prevention (CDC) Tuberculosis. https://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm
Klopper, M., Warren, R.M., Hayes, C., Gey van Pittius, N.C., Streicher, E.M., Müller, B., Sirgel, F.A., Chabula-Nxiweni, M., Hoosain, E., Coetzee, G., van Helden, P.D., Victor, T.C. and Trollip, A.P. (2013) Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa. Emerging Infectious Diseases, 19, 449-455. https://doi.org/10.3201//EID1903.120246
Lobue, P. (2006) Extensively Drug-Resistant Tuberculosis. Current Opinion in Infectious Diseases, 12, 1311-1318.
Pai, M., Kalantri, S., Aggarwal, A.N., Menzies, D. and Blumberg, H. (2006) Nosocomial Tuberculosis in India. Emerging Infectious Diseases, 12, 1311-1319. https://doi.org/10.3201/eid1209.051663
Prasad, R., Gupta, N. and Singh, M. (2014) Multidrug Resistant Tuberculosis: Trends and Control. Indian Journal of Chest Diseases and Allied Sciences, 56, 237-246.
Agarwal, R. (2005) Treatment of Latent Tuberculosis Infection in India: Is It Worth the Salt? Lung India, 22, 105-106.
Aggarwal, A. (2009) Tuberculosis Transmission at Healthcare Facilities in India. Lung India, 26, 33-34. https://doi.org/10.4103/0970-2113.48893
Bying-Maddick, R. and Noursadeghi, M. (2016) Does Tuberculosis Threaten Our Ageing Populations? BMC Infectious Diseases, 16, 119. https://doi.org/10.1186/s12879-016-1451-0
World Health Organization (2014) Global Tuberculosis Report 2014. http://www.who.int/tb/publications/global_report/gtbr14_executive_summary.pdf
McNerney, R. and Zumla, A. (2015) Impact of the Xpert MTB/RIF Diagnostic Test for Tuberculosis in Countries with a High Burden of Disease. Current Opinion in Pulmonary Medicine, 21, 304-308. https://doi.org/10.1097/MCP.0000000000000161
Al-Orainey, I. (2009) Diagnosis of Latent Tuberculosis: Can We Do Better? Annals of Thoracic Medicine, 4, 5-9. https://doi.org/10.4103/1817-1737.44778
WHO (2019) WHO End TB Strategy. https://www.who.int/tb/post2015_strategy/en/